IBNSINA PHARMA |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.43 EGP | -5.81% |
|
-11.31% | -22.61% |
| 03/03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 05/02 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
| Sales 2024 * | 36.64B 769M 64.16B | Sales 2025 * | 44.09B 925M 77.18B | Capitalization | 2.45B 51.4M 4.29B |
|---|---|---|---|---|---|
| Net income 2024 * | 417M 8.75M 730M | Net income 2025 * | 417M 8.75M 730M | EV / Sales 2024 * | 0.17 x |
| Net Debt 2024 * | 3.65B 76.57M 6.39B | Net Debt 2025 * | 3.56B 74.75M 6.24B | EV / Sales 2025 * | 0.14 x |
| P/E ratio 2024 * |
8.1
x | P/E ratio 2025 * |
6.31
x | Employees | 5,500 |
| Yield 2024 * |
1.6% | Yield 2025 * |
3.18% | Free-Float | 61.4% |
More Fundamentals
* Assessed data
More news
| 1 day | -5.81% | ||
| 1 week | -11.31% | ||
| Current month | +1.67% | ||
| 1 month | -5.08% | ||
| 3 months | -24.77% | ||
| 6 months | +8.48% | ||
| Current year | -22.61% |
1 week
2.40
3.05
1 month
2.363.05
Current year
2.364.15
1 year
1.604.15
3 years
1.104.15
5 years
1.108.35
10 years
1.108.77
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18/00/18 | |
| Chief Executive Officer | - | 18/00/18 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chief Executive Officer | - | 18/00/18 | |
| Chief Executive Officer | - | 18/00/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/24/28 | 2.43 | -5.81% | 12,224,321 |
| 24/24/24 | 2.58 | -8.51% | 31,964,310 |
| 23/24/23 | 2.82 | -2.76% | 38,097,040 |
| 22/24/22 | 2.9 | +5.84% | 13,753,820 |
End-of-day quote Egyptian Exchange, April 28, 2024
More quotes
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Sector
Drug Retailers
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.43
EGP
Average target price
4.082
EGP
Spread / Average Target
+68.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.61% | 51.14M | |
| -32.21% | 15.27B | |
| -30.05% | 10.84B | |
| -28.54% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -1.17% | 4.69B | |
| +52.19% | 4.29B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
- Stock Market
- Equities
- ISPH Stock
